MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Genetics"

  • 2023 International Congress

    Progressive myoclonus ataxia and resting tremor in hypoceruloplasminemia

    L. Pollini, M. Novelli, F. Nardecchia, K. Bernardi, E. Colacino, F. Pisani, V. Leuzzi, S. Galosi (Rome, Italy)

    Objective: To describe two familiar cases of hypoceruloplasminemia presenting with movement disorders Background: Aceruloplasminemia is a metabolic disorder caused by mutations in the ceruloplasmin (CP)…
  • 2022 International Congress

    Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada: A Multicenter Study

    S. Alshimemeri, D. Aboalsamh, L. Zhou, S. Furtado, S. Kraft, V. Bruno, A. Duquette, B. Brais, O. Suchowersky, R. Munhoz, E. Slow (Riyadh, Saudi Arabia)

    Objective: To describe the demographics and clinical characteristics of Autosomal Dominant (AD) Spinocerebellar Ataxias (SCA) in the Canadian population. Background: SCAs are a group of…
  • 2022 International Congress

    Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype

    Y. Salamatova, L. Terpak, E. Giatour, N. Shneyder (jacksonville, USA)

    Objective: To present case series of four patients of heterozygous for SYNE1 mutation with phenotype consistent with cerebellar ataxia. Background: Recessive cerebellar ataxias are defined as disorders with autosomal recessive…
  • 2022 International Congress

    A CASE REPORT OF EARLY-ONSET SPINOCEREBELLAR ATAXIA TYPE 35

    I. Delpino Delaguno, C. Derojas Leal, O. León Plaza, MJ. Gómez Heredia, F. Pérez Errazquin (Málaga, Spain)

    Objective: To broaden diagnostic testing of likely genetic ataxias. Background: Spinocerebellar ataxia (SCA) refers to a heterogeneous group of degenerative genetic disorders which encompasses a…
  • 2022 International Congress

    Diagnostic yield for point mutation related SCAs through exome sequencing for undetermined ataxias

    JL. Pedroso, T. Silva, M. França Jr, O. Barsottini (São Paulo, Brazil)

    Objective: To describe the diagnostic yield of whole exome sequencing (WES) to identify autosomal dominant spinocerebellar ataxias (SCAs) caused by point mutations. Background: There are…
  • 2022 International Congress

    Two Different Clinical Presentations in SYNE1 Ataxia in Turkey

    Y. Secil, A. Subasioglu (İzmir, Turkey)

    Objective: SYNE1 (Spectrin repeat-containing nuclear envelope protein 1) gene mutation, first diagnosed in French Canadians in 2007, is now reported from many regions around the…
  • 2022 International Congress

    Late-onset cerebellar ataxia: case report of a new CNV on TTBK2 gene as possible cause of SCA-11

    I. Rodríguez (Monterrey, Mexico)

    Objective: To describe a case of  spinocerebellar ataxia type 11 caused by the copy number variant 43008859_43075833 on the TKKB2 gene Background: The spinocerebellar ataxias…
  • 2022 International Congress

    LIG1 polymorphism modifies the age at onset in patients with Spinocerebellar Ataxia type 2

    LE. Almaguer-Mederos, D. Cuello-Almarales, R. Aguilera-Rodríguez, D. Almaguer-Gotay, Y. González-Zaldívar, R. Lamas-González, S. Gispert, G. Auburger (Holguin, Cuba)

    Objective: Assessing the role of LIG1 Exon 6 A→C polymorphism acting as a modifier of clinical severity in patients with Spinocerebellar ataxia type 2 (SCA2).…
  • 2022 International Congress

    DHDDS and NUS1: A converging pathway and common phenotype

    L. Williams, J. Qiu, S. Waller, N. Elserafy, M. Tchan, P. Procopis, H. Sampaio, S. Mohammad, H. Morales-Briceño, V. Fung (Sydney, Australia)

    Objective: To report on the clinical spectrum of variants affecting dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate Synthase 1 (NUS1) and particularly to highlight their…
  • 2022 International Congress

    Conservative iron chelation for Neuroferritinopathy

    F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)

    Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 28
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley